The physics behind LSCI is elegantly simple. When coherent laser light strikes living tissue, the moving red blood cells beneath the surface scatter the light, and the interference of those scattered waves produces a granular pattern of bright and dark spots known as speckle. The faster the blood flows through the microvasculature, the more rapidly the speckle pattern fluctuates; the slower the perfusion, the more static the grain becomes. By analysing the spatial blurring of consecutive speckle images, the technique converts these fluctuations into quantitative maps of blood flow, expressed in perfusion units, without ever touching the skin. Because it is non-contact, high-resolution and real-time, LSCI has long been used in research settings to monitor cerebral blood flow and wound healing. What makes the new study distinctive is its attempt to link those perfusion maps directly to the experience of pain, exploiting a well-known but rarely quantified phenomenon: acute noxious stimulation triggers sympathetic vasoconstriction, causing peripheral blood flow to drop.

The human experiments began with sixty healthy volunteers, divided into three independently recruited cohorts of twenty. Each group endured a different kind of controlled pain: pressure stimulation, cold stimulation, or electrical stimulation. Crucially, the intensity of each stimulus was individually titrated until the participant reported a numeric rating scale score greater than four, ensuring that every person experienced a genuinely painful, suprathreshold event rather than a merely uncomfortable one. The researchers recorded perfusion in a defined region of interest before and during stimulation. In all three modalities, the result was consistent: both the median and the minimum perfusion values decreased during the painful stimulus. The drop in skin blood flow, in other words, tracked the delivery of noxious input regardless of whether that input was mechanical, thermal or electrical—a striking convergence across three very different pain pathways.

The clinical centrepiece of the study, however, involved patients who were awake and genuinely anxious: 132 individuals undergoing surgery or procedures who required right radial artery puncture, one of the more acutely painful routine interventions in anaesthesiology. Before and during the puncture, the team recorded perfusion from the contralateral hand, wrist or distal forearm—sites far removed from the needle, so that local tissue trauma could not confound the signal. Immediately afterwards, patients rated their pain on the numeric rating scale. The analysis revealed that median and minimum perfusion features correlated negatively with self-reported pain intensity: the more the distant skin perfusion fell, the more pain the patient reported. The strongest inverse associations came from the region-of-interest minimum ratio and difference, with Spearman correlation coefficients of −0.428 and −0.425 respectively, both statistically significant at P less than 0.001. In the messy, uncontrolled environment of a real procedure room, the optical signal still carried information about subjective suffering.

Encouraged by these correlations, the researchers took an exploratory step further and derived a composite metric they named the LSCI Nociception Index, or LNI, built exclusively from perfusion ratios. Evaluated within the same patient cohort from which it was derived, the index achieved an apparent area under the receiver operating characteristic curve of 0.80, with a 95 percent confidence interval of 0.73 to 0.87, for detecting patients reporting pain scores above four on the ten-point scale. A bootstrap optimism correction trimmed that figure to 0.79, suggesting the in-sample performance was not entirely an artefact of overfitting. Still, the authors are careful to label these as internal estimates. An index trained and tested on the same 132 patients has not yet proven itself on strangers, and the team explicitly states that external validation in independent cohorts is required before the LNI could be considered for any clinical monitoring application.

To probe whether the technique could detect nociception when self-report is impossible, the researchers turned to an animal model. Thirty male mice underwent plantar incision—a standard surgical pain model—under either propofol or isoflurane anaesthesia, with each anaesthetic combined in separate subgroups of five animals with saline, low-dose morphine, or high-dose morphine. LSCI monitoring of the hind paw revealed stage-specific perfusion reductions following incision, and, remarkably, morphine attenuated those surgical perfusion reductions in a dose-ordered pattern under both anaesthetic regimens. In other words, the optical signal did not merely register tissue trauma; it registered the pharmacological blunting of the nociceptive response. This is precisely the behaviour one would hope for in a nociception monitor: a signal that rises with noxious input and falls when analgesia is effective.

The authors are equally candid about the limits of the mouse experiments. The subgroups contained only five animals each, far too few for robust statistical inference, and morphine is a vasodilator as well as an analgesic, meaning some of the observed perfusion changes could reflect direct vascular effects of the drug rather than modulation of nociceptive signalling. Disentangling haemodynamic pharmacology from genuine antinociception will require larger, better-controlled studies, possibly using analgesics with different vascular profiles. Until then, the animal arm of the study should be read as an exploratory proof of principle rather than a validated method for assessing anaesthetic depth or analgesic adequacy in the operating room.

Even so, the implications are considerable. Intraoperative nociception monitoring is a persistent unmet need in anaesthesiology. Anaesthetised patients cannot report pain, and existing monitors infer nociceptive state indirectly from heart rate variability, skin conductance or surgical plethysmography, each with known weaknesses. A camera that watches a patient’s hand from across the operating table and reports, in real time, whether the microcirculation is signalling pain would be a genuinely new kind of instrument—one that requires no electrodes, no calibration to the individual, and no physical contact with sterile fields. The same technology could one day help assess pain in neonates in intensive care, in patients with disorders of consciousness, or in non-verbal adults with dementia, populations for whom the numeric rating scale is fundamentally unusable.

The study’s human findings, too, come with important caveats that the researchers state plainly. The volunteer cohorts were small, healthy and young, and each participant received only a single titrated stimulus, so the results say little about chronic pain, repeated stimulation, or patients with vascular disease, diabetes or autonomic dysfunction—conditions that independently alter peripheral perfusion and could confound the signal. The patient cohort was selected rather than randomised, and the correlation coefficients, while highly significant, explain only a modest fraction of the variance in pain scores. No single physiological variable will ever fully capture an experience shaped by emotion, expectation and memory. LSCI is best understood not as a pain meter but as one objective channel of information about the body’s nociceptive state, to be interpreted alongside clinical context.

What the study ultimately delivers is a bridge between two worlds that have long struggled to communicate: the subjective, first-person reality of pain and the objective, third-person language of physiology and instrumentation. By showing that a simple laser camera can detect reproducible perfusion changes tied to acute pain in awake humans and to analgesia-modulated nociception in mice, the Chongqing team has laid the groundwork for a line of translational research that could reshape how clinicians assess suffering in those who cannot describe it. The path from proof of concept to bedside monitor runs through external validation, larger and more diverse cohorts, and careful separation of vascular from neural effects. But the destination—a future in which pain leaves a measurable optical fingerprint—is now visibly closer, and the speckle pattern on a patient’s skin may soon speak where words cannot.

Subject of Research: Laser speckle contrast imaging as an objective physiological measure of pain and nociception

Article Title: Laser speckle contrast imaging as an objective physiological readout associated with pain and nociception

Article References: Zhang, Y., Li, H., Lv, R., Yang, Y., Feng, Y., Tao, C., Chen, Y., Nie, D., Ju, D., Duan, G., & Huang, H. (2026). Laser speckle contrast imaging as an objective physiological readout associated with pain and nociception. BMC Medicine. https://doi.org/10.1186/s12916-026-05240-w

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05240-w

Keywords: laser speckle contrast imaging, pain measurement, nociception, microcirculation, blood perfusion, biomedical optics, analgesia, anesthesiology, LSCI Nociception Index, translational research, BMC Medicine, pain biomarker

The core problem the researchers set out to solve is deceptively simple to state. Wound healing in diabetes is a complex, slow and frequently derailed biological process, often complicated by infection and poor blood supply. Clinical assessment currently relies on visual examination and surface measurement, methods the authors describe as strongly subjective and incapable of evaluating what lies beneath the wound bed. A wound may look dry and closed while the microvascular network beneath it remains dysfunctional and fragile, a mismatch that contributes to the high rate of ulcer recurrence. What is needed, the team argued, is a way to quantify the repair process itself: how blood flows through the skin, how new vessels sprout and mature, and how the internal architecture of the wound remodels over time.

No single imaging modality can capture all of that at once, which is precisely why the researchers combined three. The first is laser speckle contrast imaging, or LSCI, a technique that shines coherent laser light across the wound surface and reads the interference patterns, or speckles, produced by moving red blood cells. Because the blurring of the speckle pattern is directly related to the speed of blood flow, LSCI can generate real-time, full-field maps of cutaneous blood perfusion without any contrast agent, any contact and any ionizing radiation. It is essentially a live weather map of circulation at the wound surface, refreshed many times per second.

The second technique reaches deeper into the near-infrared spectrum. Second near-infrared region imaging, known as NIR-II, operates at wavelengths roughly between 1,000 and 1,700 nanometers, where tissue scatters far less light than in the visible range. The result is dramatically improved penetration depth and spatial resolution, allowing the team to trace the spatial and temporal evolution of vascular networks as they regrew across the healing wounds. Whereas LSCI reports on how fast blood moves, NIR-II delineates the plumbing itself, the architecture of the vessels carrying that blood, resolved in three dimensions over days and weeks.

The third modality, optical coherence tomography angiography, or OCTA, borrows the depth-resolving power of OCT and applies it to moving blood cells. By detecting flow-induced changes in repeated cross-sectional scans, OCTA reconstructs high-resolution maps of microvessels without injecting any dye, while simultaneously characterizing the internal microarchitecture of the wound. Together the three techniques span a striking range of scales: LSCI for dynamic whole-surface perfusion, NIR-II for vascular network structure over time, and OCTA for depth-resolved microvascular and tissue detail. The researchers describe the resulting dataset as a uniquely comprehensive record of the microvascular repair process, one that no individual modality could deliver on its own.

To put the platform to the test, the team carried out longitudinal imaging of full-thickness skin wounds in both normal mice and db/db mice, a widely used model of type 2 diabetes in which wounds heal slowly and incompletely, mirroring the clinical situation. All animal work was conducted between August 2024 and March 2025 under protocols approved by the Ethics Committee of the Second Hospital of Shanxi Medical University, in accordance with National Institutes of Health guidelines, with anesthesia, analgesia and standard-compliant postoperative care to minimize suffering. The multimodal setup allowed the same wounds to be tracked continuously through the entire healing trajectory, a demanding experimental design that required synchronizing three optical systems around a single wound site over many sessions.

The results demonstrated that each modality pulled its weight, and that their combination produced information neither could supply alone. LSCI captured real-time dynamic changes in cutaneous blood perfusion, revealing how flow returned, fluctuated and redistributed across the wound surface as healing advanced. NIR-II imaging traced the growth and remodeling of vascular networks in space and time, documenting the emergence of new vessel structures that later consolidated. OCTA, meanwhile, peered inside the wound to characterize microarchitecture and microvascular patterns at high resolution, exposing differences between normally healing wounds and the impaired regeneration seen in the diabetic animals. The platform thereby enabled both qualitative and quantitative assessment of wound repair capacity, with the authors describing the resolution and completeness of the data as unprecedented.

Beyond simply watching wounds close, the study had a therapeutic ambition. The team used the platform to quantitatively evaluate zinc-ion-based treatment strategies aimed at promoting the reconstruction of microcirculation in diabetic wounds. Zinc has long interested wound researchers for its roles in enzymatic function, immune defense and angiogenesis, but demonstrating that a pro-angiogenic therapy is actually rebuilding functional vessels, rather than merely shrinking a wound, requires exactly the kind of vascular-level measurement the new platform provides. By combining perfusion data from LSCI, structural vascular data from NIR-II and depth-resolved microvascular data from OCTA, the researchers could assess treatment effects across multiple physiological dimensions simultaneously, rather than inferring efficacy from wound area alone.

The implications for clinical practice could be significant. Diabetic wound care currently suffers from a measurement gap: decisions about debridement, dressings, revascularization procedures and amputation are guided largely by surface appearance, photographs and manual measurements, supplemented in some centers by transcutaneous oxygen testing or Doppler ultrasound. Laser Doppler flowmetry, an older optical perfusion technique, measures flow only at single points, while indocyanine green angiography requires an injected dye and offers limited depth information. The platform presented by the Shanxi team addresses these shortcomings by fusing agent-free, contact-free measurements of flow, vessel architecture and tissue structure into a single longitudinal record. The authors argue that the approach demonstrates promising feasibility for assessing novel pro-angiogenic treatments and may eventually help guide clinical wound management, although translation from mice to patients will require further validation, including work on appropriate imaging windows for human tissue and the workflow demands of busy clinics.

The study also fits into a broader movement in biomedical optics toward multimodal, quantitative imaging of disease processes. Techniques such as polarization-sensitive OCT, magnetic resonance angiography and advanced fluorescence imaging each contribute pieces of the wound-healing picture, but their integration into a practical bedside workflow remains an open challenge. What the Shanxi team has shown is that three optical methods with overlapping but distinct strengths can be orchestrated to produce a coherent, quantifiable narrative of tissue repair, from the first surge of perfusion at the wound margin to the maturation of a new capillary network beneath a closing epithelium. If that narrative can eventually be read in a human clinic as reliably as it now can in a mouse model, the humble ruler may finally give way to a far more revealing instrument, one that sees not just whether a wound is closing but whether the vessels underneath it are truly built to last.

Subject of Research: Multimodal noninvasive optical imaging of microvascular repair in diabetic wound healing

Article Title: Noninvasive assessment of the repair process in diabetic wound healing using multimodal imaging techniques

Article References: Li, Y., Zhang, H., Ren, Y., Wang, H., Cao, G., Fan, K., Lu, C., Zhang, Y., Han, J., & Dong, H. (2026). Noninvasive assessment of the repair process in diabetic wound healing using multimodal imaging techniques. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02811-4

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02811-4

Keywords: diabetic wound healing, laser speckle contrast imaging, NIR-II imaging, OCTA, angiogenesis, blood perfusion, microcirculation, noninvasive imaging, db/db mice, wound assessment, biomedical optics, zinc therapy